Indicated for the treatment of chronic HCV infection in adults: Pan-genotypic: Effective against Genotypes 1, 2, 3, 4, 5, and 6. Liver Status: For patients without cirrhosis or with compensated cirrhosis. Decompensated Cirrhosis: Used in combination with Ribavirin.

Dosage and administration

Standard Dosage: One tablet daily for 12 weeks. ⚠️ IMPORTANT: ACID REDUCING AGENTS Velpatasvir requires gastric acid for absorption. If you use PPIs (like Omeprazole): Take Velpanat with food. Take Omeprazole (max 20 mg) 4 hours AFTER Velpanat. Separate antacids (aluminum/magnesium) by at least 4 hours.

🚫 DANGER: AMIODARONE. Do not take with Amiodarone (antiarrhythmic). This combination causes severe bradycardia and heart block. Other Contraindications: Pregnancy and breastfeeding. Co-administration with strong P-gp inducers (Rifampin, St. John's Wort) as they decrease therapeutic levels.

Side effects are typically minimal: Headache, Fatigue, Nausea. HBV Warning: Hepatitis B reactivation. All patients must be screened for Hepatitis B before starting treatment to prevent potentially fatal liver failure due to HBV flare-up.

Velpanat — Sofosbuvir 400 mg + 100 mg, 28 pcs, Natco

100% original product

Active ingredient

Sofosbuvir Velpatasvir

Manufacturer

Natco

Dosage 400 mg + 100 mg

Dosage form Tablets

Tablets per pack 28

Velpanat (Sofosbuvir/Velpatasvir) 400 mg / 100 mg

Name: Velpanat
Brand: Natco
SKU: PROD-64
Price: 5054 UAH
Availability: InStock

5054₴ ~~5494₴~~ -8%

Velpanat is a premium pan-genotypic fixed-dose combination for Hepatitis C treatment. Active ingredients: Sofosbuvir (400 mg) + Velpatasvir (100 mg).

Manufacturer: Natco Pharma (India). Recognized as the highest quality generic equivalent of Epclusa.

The "One Pill for All" Solution:

Velpanat simplifies treatment by covering ALL genotypes (1-6). Manufactured by Natco, a global leader in hepatitis care, it guarantees high purity and efficacy. It is the preferred regimen for the difficult-to-treat Genotype 3.

✅ Efficacy: Cure rates exceeding 98-99% with a standard 12-week course.

Indicated for the treatment of chronic HCV infection in adults:

Pan-genotypic: Effective against Genotypes 1, 2, 3, 4, 5, and 6.
Liver Status: For patients without cirrhosis or with compensated cirrhosis.
Decompensated Cirrhosis: Used in combination with Ribavirin.

Standard Dosage: One tablet daily for 12 weeks.

⚠️ IMPORTANT: ACID REDUCING AGENTS

Velpatasvir requires gastric acid for absorption. If you use PPIs (like Omeprazole):

Take Velpanat with food.
Take Omeprazole (max 20 mg) 4 hours AFTER Velpanat.
Separate antacids (aluminum/magnesium) by at least 4 hours.

🚫 DANGER: AMIODARONE.

Do not take with Amiodarone (antiarrhythmic). This combination causes severe bradycardia and heart block.

Other Contraindications:

Pregnancy and breastfeeding.
Co-administration with strong P-gp inducers (Rifampin, St. John's Wort) as they decrease therapeutic levels.

Side effects are typically minimal:

Headache, Fatigue, Nausea.
HBV Warning: Hepatitis B reactivation. All patients must be screened for Hepatitis B before starting treatment to prevent potentially fatal liver failure due to HBV flare-up.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 13.03.2026